Jagsonpal Pharmaceuticals Ltd. | Small-cap | Healthcare
₹220.00
1.56%
| Jagsonpal Stock Comparison:

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 2.7B
Gross Profit 1.7B 64.11%
Operating Income 429.4M 15.98%
Net Income 553.6M 20.60%

Balance Sheet Metrics

Total Assets 2.8B
Total Liabilities 383.1M
Shareholders Equity 2.4B
Debt to Equity 0.16

Cash Flow Metrics

Operating Cash Flow 532.9M
Free Cash Flow 549.5M

Revenue & Profitability Trend

Jagsonpal Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 2.7B 2.1B 2.4B 2.2B 1.9B
Cost of Goods Sold 964.4M 801.3M 925.1M 892.8M 809.3M
Gross Profit 1.7B 1.3B 1.4B 1.3B 1.1B
Operating Expenses 502.7M 424.4M 420.3M 420.8M 308.9M
Operating Income 429.4M 216.7M 343.3M 245.4M 187.9M
Pre-tax Income 698.6M 298.7M 348.1M 266.4M 218.7M
Income Tax 145.0M 74.1M 80.9M 77.9M 48.1M
Net Income 553.6M 224.6M 267.2M 188.6M 170.6M
EPS (Diluted) - ₹3.38 ₹4.08 ₹2.88 ₹2.60

Income Statement Trend

Jagsonpal Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 1.6B 2.0B 1.6B 1.1B 1.2B
Non-Current Assets 1.2B 178.2M 303.9M 551.4M 461.9M
Total Assets 2.8B 2.2B 1.9B 1.6B 1.6B
Liabilities
Current Liabilities 259.0M 191.3M 275.7M 269.7M 375.8M
Non-Current Liabilities 124.1M 105.5M 84.8M 44.9M 23.5M
Total Liabilities 383.1M 296.8M 360.6M 314.7M 399.4M
Equity
Total Shareholders Equity 2.4B 1.9B 1.6B 1.3B 1.2B

Balance Sheet Composition

Jagsonpal Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 698.6M 298.7M 348.1M 266.4M 218.7M
Operating Cash Flow 532.9M 497.0M 550.9M 156.5M 333.6M
Investing Activities
Capital Expenditures 353.7M -2.5M 9.8M -4.7M -4.7M
Investing Cash Flow -529.9M -319.2M -611.0M -289.2M -46.4M
Financing Activities
Dividends Paid -132.3M -131.0M - -104.8M -26.2M
Financing Cash Flow -98.4M -74.6M -3.2M -240.5M -26.2M
Free Cash Flow 549.5M 349.2M 463.4M 58.6M 277.5M

Cash Flow Trend

Jagsonpal Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 26.36
Price to Book 6.07
Price to Sales 5.37

Profitability Ratios

Profit Margin 20.60%
Operating Margin 10.94%
Return on Equity 25.91%
Return on Assets 10.84%

Financial Health

Current Ratio 6.22
Debt to Equity 3.85
Beta 0.15

Per Share Data

EPS (TTM) ₹8.23
Book Value per Share ₹35.72
Revenue per Share ₹40.09

Financial data is updated regularly. All figures are in the company's reporting currency.